Exposure–Response Relationship of T-DM1: Insight Into Dose Optimization for Patients With HER2-Positive Metastatic Breast CancerJ Wang, Atiqur Rahman, Qiang Xu et al.|Clinical Pharmacology & Therapeutics|2014Cited by 65
A population pharmacokinetic model for zoledronic acid (ZOMETA) in patients with bone metastasesB Booth, Jogarao Gobburu, Atiqur Rahman et al.|Clinical Pharmacology & Therapeutics|2003Cited by 3